
Bristol Woman Misdiagnosed with Pregnancy at 17 Fights for Life-Saving Off-Label Treatment
A 26-year-old Bristol woman who was initially told by doctors that she was pregnant—when she actually had a rare form of cancer—is raising thousands of pounds for an off-label drug in a bid to buy precious time until a cure is found.
Nine years after her initial misdiagnosis, Verity Barker and her mother, Lydia Grant, are appealing to the public to help fund Enhertu, a treatment costing £4,785 per dose.
Verity was diagnosed with Desmoplastic Small Round Cell Tumour (DSRCT), an extremely rare and aggressive sarcoma, two years after doctors originally mistook her symptoms for a pregnancy and later ovarian cancer.
After enduring major surgeries, intensive chemotherapy, and clinical trials over nearly a decade, Verity was given the devastating news last summer that her liver was failing and she had just months to live. However, after a successful procedure to insert a liver stent, her family is now pinning their hopes on Enhertu to keep her tumours at bay.

Photo: John Stead
A Nine-Year Battle
Verity’s journey began at age 17 when she visited her GP feeling bloated, exhausted, and unable to lie down comfortably. Despite multiple negative tests, doctors sent her for an ultrasound believing she was 12 weeks pregnant.
The scan revealed a large mass—initially thought to be a cyst—which turned out to be cancer. During emergency surgery, doctors removed a 25cm tumour along with her left ovary and appendix. It was not until 2019, following a recurrence involving 22 abdominal tumours and advanced genetic testing, that she received the correct diagnosis of DSRCT.
“Our drug options are down to one: Enhertu,” says Verity’s mother, Lydia Grant, who has set up a dedicated fundraising page. “According to worldwide research, and our worldwide friends with DSRCT, Enhertu works effectively to reduce tumours and give patients more time to live.”
Because the NHS does not currently fund Enhertu for this specific, non-approved sarcoma subtype, the family must pay for the off-label treatment privately. The drug must be administered every three weeks, with the annual cost running into tens of thousands of pounds.
Hoping for a Breakthrough
Medical researchers are actively working on treatments for DSRCT, with Sarcoma UK currently funding two key research projects led by Professor Janet Shipley at the Institute of Cancer Research.
“DSRCT is incredibly rare and has very few treatment options,” explains Dr Sorrel Bickley, Director of Research, Policy and Support at Sarcoma UK. “Both projects aim to find more effective and gentler treatments for young people like Verity, who so often face intensive chemotherapy and major surgery that does not work long term.”
For Verity, who married her partner Luke in 2022 and works as an advocate with the Teenage Cancer Trust’s Youth Advisory Group, the goal is simple: survive long enough for research to catch up.
“There is a lot of research going on around the world to find a cure for DSRCT, and doctors are hopeful this will be achieved in the next few years,” Lydia added. “Our goal is to keep Verity alive to see this day.”
Verity remains resolute: “Stay as well as you can for as long as you can because things change every day and, after nine years, I feel I deserve to see, reach and receive a cure for this.”

How to Help
To support the appeal and contribute to Verity’s ongoing treatment fund, visit the official GoFundMe page: https://www.gofundme.com/f/viva-verity
To check out the latest local news, community updates, and charity coverage across the region, visit Direct Local Bristol.






